World Media Directory · RSS · Email Newsletters

There were 830 press releases posted in the last 24 hours and 169,901 in the last 365 days.

Healthcare & Pharmaceuticals Industry Press Releases

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire

104,184 Press Releases · RSS · Email

Published on November 18, 2019 - 13:00 GMT

H-CYTE Raises $6 Million to Accelerate FDA Approval Process of Next Generation Cellular Therapy for COPD

TAMPA, Fla., Nov. 18, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute, announces it has raised $6 million in new funding. The …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 18, 2019 - 13:00 GMT

Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination ...

REHOVOT, Israel and BRIDGEWATER, N.J., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (Foamix or the Company), a specialty pharmaceutical company, today announced the completion of Phase 2 clinical trial enrollment of FCD105 …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 18, 2019 - 12:52 GMT

BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance

Westport, CT, Nov. 18, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 18, 2019 - 12:51 GMT

Sweeping Agreement Inked by World Health Organization (WHO) and African Union to Accelerate Vital Health Goals

Download logo Today the African Union (AU) Commission and the World Health Organization (WHO) signed an historic Memorandum of Understanding (MoU) cementing their mutual commitment to expand and deepen their relationship and cooperation. The document was …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on November 18, 2019 - 12:30 GMT

Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary ...

DUBLIN, Ireland and CHICAGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 18, 2019 - 12:30 GMT

Metacrine to Present at Jefferies 2019 London Healthcare Conference

SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, today announced that Ken Song, M.D., …

Distribution channels:
Published on November 18, 2019 - 12:30 GMT

Tauriga Sciences, Inc. to Operate Main Floor Exhibitor Booth at CBD.io 2019 at the Las Vegas Convention Center on November 22-23, ...

Tauriga Sciences Inc. -- Main Floor Booth # 2422 NEW YORK, NY, Nov. 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, …

Distribution channels:
Published on November 18, 2019 - 12:30 GMT

Matinas BioPharma to Present at the 31st Annual Piper Jaffray Healthcare Conference

BEDMINSTER, N.J., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical stage biopharmaceutical company, today announced that Jerome D. Jabbour, Chief Executive Officer, has been invited to present a company …

Distribution channels:
Published on November 18, 2019 - 12:23 GMT

ProQR to Present at Upcoming Scientific Conferences

LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on November 18, 2019 - 12:00 GMT

Microbix Wins Ontario Business Award

MISSISSAUGA, Ontario, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices (QAPs™) that help …

Distribution channels:
Published on November 18, 2019 - 12:00 GMT

Eko and Mayo Clinic Prove Heart Failure is Detectable at Point of Care Using ECG-Enabled Stethoscope

SAN FRANCISCO , Nov. 18, 2019 (GLOBE NEWSWIRE) -- On November 16 at the American Heart Association Scientific Sessions 2019, Eko, a digital health company applying artificial intelligence (AI) and machine learning in the fight against heart disease, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 18, 2019 - 12:00 GMT

European Medicines Agency Grants Orchard Therapeutics Accelerated Assessment of OTL-200 for Patients with Metachromatic ...

BOSTON and LONDON, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on November 18, 2019 - 12:00 GMT

Nabriva Therapeutics Commends the CDC on the 2019 Antibiotic Resistance Threats Report, Highlighting the Need for New Antibiotics ...

S. pneumoniae continues to be designated by the CDC as “Serious Threat” underscoring need for rapid detection and prevention strategies, particularly in community setting XENLETA™ has a novel mechanism of action that is different than all other …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 18, 2019 - 12:00 GMT

Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance ...

-Molecular Templates to receive $38 million upfront payment, including equity investment, with potential for additional milestone and royalty payments on future sales- BOSTON and AUSTIN, Texas, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Vertex Pharmaceuticals …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 18, 2019 - 12:00 GMT

LHC Group to Present at the 2019 Jefferies London Healthcare Conference

LAFAYETTE, La., Nov. 18, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the 2019 Jefferies London Healthcare Conference in London, England on Wednesday, November 20, 2019 at 9:20 a.m. Greenwich …

Distribution channels:
Published on November 18, 2019 - 12:00 GMT

Ziopharm Oncology Updates Presentation and Webcast Time at the Jefferies 2019 London Healthcare Conference

BOSTON, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP) today announced that the Company’s presentation at the Jefferies 2019 London Healthcare Conference on November 20, 2019, has been moved to 1:20 p.m. GMT (8:20 a.m. ET). To …

Distribution channels:
Published on November 18, 2019 - 11:30 GMT

Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day

Details clinical plans for phase 1/1b clinical studies of SRF617 and SRF388 in patients with advanced solid tumors Shares preclinical data for new, CD112R targeted antibody candidate, SRF813, and its ability to promote NK/T cell activation CAMBRIDGE, Mass …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on November 18, 2019 - 11:30 GMT

Emergent BioSolutions to Host 2019 Analyst and Investor Day

GAITHERSBURG, Md., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will be hosting an analyst and investor day on November 21, 2019 from 8:00 AM EST to 2:00 PM EST in New York City. This event is designed for sellside research …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on November 18, 2019 - 11:00 GMT

Parallax Health Sciences Reports Third Quarter 2019 Financial Results

SANTA MONICA, Calif., Nov. 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax”), an outcome-driven connected healthcare company, reports financial results for the three and nine months ended September 30 …

Distribution channels:
Published on November 18, 2019 - 08:06 GMT

The Goodly Company and Doc of Detox Offer Nutritional Supplements with Humic Acid, Fulvic Acid, and Life Crystals

BOCA RATON, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Doc of Detox now offers American consumers several nutritional products that utilize Humic Acid, Fulvic Acid, and Life Crystals. “We are bringing to the United States several Doc of Detox nutritional products,” …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Previous 3 4 5 6 7 8 9 10 11 12 13 Next

EIN Presswire

Back to top

Quick Links:

Resources:

Press Releases:

Featured Clients:

Help & Information Center:

EIN News Home
About EIN News

Founded in 1995, EIN News is an international leader in real-time news tracking and digital information services. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The data is then filtered and organized into news streams. The process is supervised by a team of professional news editors.

We are news professionals and technologists dedicated to producing the fastest and most comprehensive news streams on the planet. We are committed to providing our members with the highest quality software tools and resources available.

EIN News is a division of Internet Product Development Group Inc.
To reach us send an email or call +1 (202) 335-3939.
EIN Presswire
Events & Conferences
Newsfeed Maker
Inbox Robot
IPD Group
EIN Twitter
EIN Facebook